Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nanocrystalline silver cream in atopic dermatitis
NCT00076375Phase 2Completed
- Sponsor
- Nucryst Pharmaceuticals
- Start
- Nov 2003
- Modality
- Nanoparticles, DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of silver nanoparticles in atopic dermatitis (AD), sponsored by Nucryst Pharmaceuticals. Started Nov 2003; status: completed.
02
Drugs
silver nanoparticles
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT00076375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00076375.